Related Experiment Video

Updated: Aug 20, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Srcasm modulates EGF and Src-kinase signaling in keratinocytes

Weijie Li1, Christine Marshall, Lijuan Mei

  • 1Department of Dermatology, University of Pennsylvania Medical School, 415 Curie Blvd., Philadelphia, PA 19104, USA.

The Journal of Biological Chemistry
|December 8, 2004
PubMed

Insights

Srcasm protein activates Src-family kinases (SFKs) and enhances epidermal growth factor (EGF) signaling in skin cells. This molecule influences cell growth and differentiation, and its levels are reduced in skin cancer.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Cancer research

Background:

  • Srcasm is a novel activator and substrate of Src-family tyrosine kinases (SFKs).
  • Its precise role in cellular signaling pathways remains largely uncharacterized.

Purpose of the Study:

  • To investigate the role of Srcasm in epidermal growth factor (EGF) receptor signaling in keratinocytes.
  • To elucidate the functional consequences of Srcasm modulation on cellular processes like proliferation and differentiation.

Main Methods:

  • Utilized keratinocytes to study endogenous and transduced Srcasm.
  • Investigated tyrosine phosphorylation, SFK activation, and downstream signaling pathways (MAPK, Elk-1).
  • Assessed effects of Srcasm on keratinocyte proliferation and differentiation; analyzed Srcasm levels in human cutaneous neoplasia.

Main Results:

  • EGF receptor ligands induce Srcasm tyrosine phosphorylation, which in turn activates SFKs (Fyn and Src).
  • Srcasm potentiates EGF-dependent SFK signaling, enhancing MAPK activity and Elk-1 transcription.
  • Elevated Srcasm inhibits keratinocyte proliferation but promotes differentiation; Srcasm levels are decreased in skin cancers.

Conclusions:

  • Srcasm acts as a crucial link between EGF receptor and SFK signaling pathways in keratinocytes.
  • Srcasm plays a significant role in regulating keratinocyte differentiation.
  • Reduced Srcasm expression is associated with human cutaneous neoplasia, suggesting a potential tumor suppressor role.

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...